Literature DB >> 10471179

Surveillance and impact of influenza in the United States.

A Klimov1, L Simonsen, K Fukuda, N Cox.   

Abstract

Mesh:

Year:  1999        PMID: 10471179     DOI: 10.1016/s0264-410x(99)00104-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  22 in total

1.  Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza.

Authors:  Ilona Jaspers; Katherine M Horvath; Wenli Zhang; Luisa E Brighton; Johnny L Carson; Terry L Noah
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-30       Impact factor: 6.914

Review 2.  Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines.

Authors:  Andrea Orsi; Filippo Ansaldi; Daniela de Florentiis; Antonella Ceravolo; Valentina Parodi; Paola Canepa; Martina Coppelli; Giancarlo Icardi; Paolo Durando
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

3.  Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

Authors:  I Margine; F Krammer; R Hai; N S Heaton; G S Tan; S A Andrews; J A Runstadler; P C Wilson; R A Albrecht; A García-Sastre; P Palese
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

4.  Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection.

Authors:  Lynnelle A McNamee; Allen G Harmsen
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

5.  A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.

Authors:  Feng Liu; Xiangjie Sun; Jeffery Fairman; David B Lewis; Jacqueline M Katz; Min Levine; Terrence M Tumpey; Xiuhua Lu
Journal:  Virology       Date:  2016-03-21       Impact factor: 3.616

6.  Rescue of influenza B virus from eight plasmids.

Authors:  Erich Hoffmann; Kutubuddin Mahmood; Chin-Fen Yang; Robert G Webster; Harry B Greenberg; George Kemble
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

7.  H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.

Authors:  Irina Margine; Rong Hai; Randy A Albrecht; Gerlinde Obermoser; A Carson Harrod; Jacques Banchereau; Karolina Palucka; Adolfo García-Sastre; Peter Palese; John J Treanor; Florian Krammer
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 8.  Cross-protective immune responses elicited by live attenuated influenza vaccines.

Authors:  Yo Han Jang; Baik Lin Seong
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

Review 9.  Influenza virus hemagglutinin stalk-based antibodies and vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Curr Opin Virol       Date:  2013-08-24       Impact factor: 7.090

10.  Estimating the undetected burden of influenza hospitalizations in children.

Authors:  C G Grijalva; G A Weinberg; N M Bennett; M A Staat; A S Craig; W D Dupont; M K Iwane; A S Postema; W Schaffner; K M Edwards; M R Griffin
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.